Pete Lee

Monday, May 08, 2006

Pete's Latest Gamble

Albeit, a relatively small one: I just purchased $117 worth of stock in a company called Indevus Pharmaceuticals solely because I was very interested in a product called PRO 2000.

This product is currently in FDA trials and is slated for release in about a year-and-a-half. It appears to offer some promise in the area of STD harm reduction: the product's microbicide effects appear to dramatically increase the difficulty of HIV and HSV-2 transmission, something I'm supportive of.

Even though it has a Buy rating, I think the company is still a high-risk investment, but fun to watch nonetheless.


Post a Comment

<< Home